The EU4Health Programme is the EU’s dedicated health funding instrument for 2021–2027, created to strengthen Europe’s resilience to health crises and improve public health across member states. It supports actions that enhance disease prevention, reinforce health systems, improve access to medicines and medical devices, and boost cooperation at EU level. Through targeted funding, EU4Health aims to build a healthier, more prepared, and more equitable Europe.
The EU4Health Programme is managed by DG SANTE (European Commission).
Open Calls
Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases.
Read more here LINK
Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve.
Read more here: LINK
The project aims to establish and maintain a European stockpile of experimental vaccines that can be quickly used during outbreaks and incorporated into emergency clinical studies. This strategy is intended to speed up vaccine clinical development beginning at Phase 2.
Deadline: 02 September 2026
Long-term stockpiling of active pharmaceutical ingredients (APIs) and rapid production of finished dose forms.
Read more here: LINK
The objective is to evaluate technologies capable of extending the shelf life of APIs, enabling flexible and rapid production in the event of health emergencies, improving the sustainability and resilience of healthcare systems
Deadline: 30 September 2026
